Literature DB >> 4547657

A new sensitive assay for antibody against cell surface antigens based on inhibition of cell-dependent antibody-mediated cytotoxicity. I. Specificity and sensitivity.

P Halloran, V Schirrmacher, H Festenstein.   

Abstract

Inhibition of cell-dependent antibody-mediated cytotoxicity has been investigated as a new assay for antibody against cell surface antigens. The cytotoxicity system consisted of effector cells (normal mouse spleen cells), target cells ((61)Cr-labeled chicken erythrocytes), and antitarget cell antibody. Addition of antibody against cell surface antigens in the effector cell population regularly inhibited the cytotoxicity measured in this system. This cytotoxicity inhibition assay (CIA) detected antibody with a variety of specificities: anti-H-2, anti-Thy 1.2, anti-immunoglobulin, and antimouse bone marrow-derived lymphocyte antigen. When the inhibition by anti-H-2 sera was analyzed using effector cells from congenic mice, the activity was found to be directed against specificities mapping in the H-2K, H-2D, and I regions of the H-2 complex, correlating well with the specificities characterized by complement-dependent assays. A comparison between the sensitivity of the CIA and complement-dependent lysis revealed that the CIA was 2-11 times more sensitive for anti-H-2 antisera and 20-780 times more sensitive for certain antisera against subpopulations of the spleen cells (i.e., T cells or B cells). The CIA proved to be precise, sensitive, and reliable. It may become a very useful antibody assay in various species including man.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4547657      PMCID: PMC2139728          DOI: 10.1084/jem.140.5.1348

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  Antibody-dependent cell-mediated cytotoxicity due to a "null" lymphoid cell.

Authors:  A H Greenberg; L Hudson; L Shen; I M Roitt
Journal:  Nat New Biol       Date:  1973-03-28

2.  Competition for receptors for immunoglobulin on cytotoxic lymphocytes.

Authors:  I C MacLennan
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

3.  Lymphocyte-dependent cytotoxic antibody activity against human transplantation antigens.

Authors:  P Hersey; P Cullen; I C MacLennan
Journal:  Transplantation       Date:  1973-07       Impact factor: 4.939

4.  The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. I. Comparison of the effects of target cell specific antibody and normal serum factors on cellular damage by immune and non-immune lymphocytes.

Authors:  I C MacLennan; G Loewi; B Harding
Journal:  Immunology       Date:  1970-03       Impact factor: 7.397

5.  B-lymphocyte mediated cytolysis: a complement independent phenomenon.

Authors:  C S Henney; J Clayburgh; G A Cole; R A Prendergast
Journal:  Immunol Commun       Date:  1972

6.  Hemolysin titration based on fixation of the activated first component of complement: evidence that one molecule of hemolysin suffices to sensitize an erythrocyte.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1965-09       Impact factor: 5.422

7.  IgM and IgG anti-hapten antibody: hemolytic, hemagglutinating and precipitating activity.

Authors:  K Onoue; N Tanigaki; Y Yagi; D Pressman
Journal:  Proc Soc Exp Biol Med       Date:  1965-11

8.  Antibody-dependent lymphoid cell-mediated cytotoxicity: no requirement for thymus-derived lymphocytes.

Authors:  J A Van Boxel; J D Stobo; W E Paul; I Green
Journal:  Science       Date:  1972-01-14       Impact factor: 47.728

9.  Antigenic structure of cell surfaces. An immunoferritin study of the occurrence and topography of H-2' theta, and TL alloantigens on mouse cells.

Authors:  T Aoki; U Hämmerling; E De Harven; E A Boyse; L J Old
Journal:  J Exp Med       Date:  1969-11-01       Impact factor: 14.307

10.  The immune response against hapten-autologous protein conjugates in the mouse.

Authors:  B Rubin; H Wigzell
Journal:  J Exp Med       Date:  1973-04-01       Impact factor: 14.307

View more
  6 in total

1.  Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases.

Authors:  J L Feldmann; M J Becker; H Moutsopoulos; K Fye; M Blackman; W V Epstein; N Talal
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

2.  Identity of effector cells participating in the reverse antibody-dependent cell-mediated cytotoxicity.

Authors:  R K Saxena; Q B Saxena; W H Adler
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

3.  Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.

Authors:  R N Germain; R M Williams; B Benacerraf
Journal:  Am J Pathol       Date:  1976-12       Impact factor: 4.307

4.  The mouse Ly-17 locus identifies a polymorphism of the Fc receptor.

Authors:  M L Hibbs; P M Hogarth; I F McKenzie
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

5.  Interactions of Fc receptors with antibodies against Ia antigens and other cell surface components.

Authors:  V Schirrmacher; P Halloran; C S David
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

6.  Antibody-dependent cellular cytotoxicity to human colon-tumour cells. II. Analysis of the antigens involved.

Authors:  J Shoham; M Cohen
Journal:  Br J Cancer       Date:  1979-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.